Today: 9 April 2026
Philip Morris stock price: PM steadies near $183 after upbeat 2026 forecast puts Zyn battle back in view
7 February 2026
1 min read

Philip Morris stock price: PM steadies near $183 after upbeat 2026 forecast puts Zyn battle back in view

New York, Feb 7, 2026, 15:18 EST — That’s it for today’s session; markets have closed.

Philip Morris International finished the day up 0.45% at $182.81. The stock picked up after the company lifted its 2026 profit outlook, pointing to momentum in its nicotine pouch business. Reuters

The situation is reaching a breaking point, with the stock turning into a barometer for whether smoke-free products can actually deliver profits in a market packed with competitors. Zyn sits at the center of the storm. Traders have their eyes glued to any hint that surging volumes aren’t eating into pricing strength.

With U.S. markets shut over the weekend, all eyes shift to what Monday brings. Profit forecasts have sharpened, yet there’s fresh anxiety: will competitors ramp up discounting? If so, margins could take a hit—fast.

Philip Morris International notched adjusted fourth-quarter earnings of $1.70 a share, up from $1.55 the previous year, with net revenues jumping 6.8% to $10.362 billion. The tobacco giant is projecting first-quarter adjusted EPS in the $1.80 to $1.85 range and has set its sights on 2026 reported diluted EPS between $7.87 and $8.02. Management also reaffirmed longer-term growth targets, emphasizing “organic” gains—those stripped of currency swings and deal impacts. Philip Morris International

Philip Morris chief Jacek Olczak told Reuters the company has revamped Zyn products in the pipeline, but any rollout depends on regulatory clearance as rivals turn up the heat. Jefferies analyst Andrei Andon-Ionita called Philip Morris’s fresh targets a “reassuring outlook” for growth, flagging British American Tobacco as a major U.S. nicotine pouch competitor. Reuters

Stocks barely flinched ahead of the weekend, while U.S. indexes shot higher on Friday. The Dow punched past 50,000 at the close, marking a record. PMI, by contrast, barely moved—some traders chalk that up to defensive cash staying out rather than chasing the rally. AP News

Desks go into early next week scanning for analyst updates and any hints about pouch market share talk. Options tend to wake up in this sort of environment; when consumer names shift on category data rather than headline spikes, flows sometimes get lively.

Even so, there’s an obvious risk here. If a price war breaks out in the pouch aisle, volume might climb, but revenue and profit per can could shrink. That’s a setup where forecasts slip, despite the company winning more shelf space.

Heated tobacco products like IQOS remain under the microscope; a quick change in taxes or pricing can swing demand sharply. Should the main markets lose momentum, the stock’s case for smoke-free growth could face real pressure.

Income-seeking investors are circling PMI’s next dividend schedule: the company announces on March 5, 2026, shares trade ex-dividend March 19, and checks are due to arrive April 13. Philip Morris International

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus
Previous Story

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

IBM stock price jumps 3% into weekend as Confluent vote and dividend date near
Next Story

IBM stock price jumps 3% into weekend as Confluent vote and dividend date near

Go toTop